Following an application from enzyme.pro.ag, submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of regulat®.pro.kid BRAIN on the mental and cognitive development of children (Question No EFSA-Q-2008-083) [The EFSA Journal (2008) 829, 1-10.]. The claim proposed by the applicant was worded as follows: ‘regulat®.pro.kid BRAIN contributes to mental and cognitive development of children’.
Recital 35, Commission Regulation (EC) No 983/2009 of 21 October 2009 on the authorisation and refus…
In forcesince 21 Oct 2009